Long-term lithium therapy and risk of chronic kidney disease, hyperparathyroidism and hypercalcemia: a cohort study
Abstract Background Lithium is well recognized as the first-line maintenance treatment for bipolar disorder (BD). However, besides therapeutic benefits attributed to lithium therapy, the associated side effects including endocrinological and renal disorders constitute important parameters in prescri...
Main Authors: | Elise Boivin, Brendan Le Daré, Romain Bellay, Cécile Vigneau, Marion Mercerolle, Astrid Bacle |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-01-01
|
Series: | International Journal of Bipolar Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40345-023-00286-8 |
Similar Items
-
Lithium-Associated Hyperparathyroidism Followed by Catatonia
by: Srinagesh Mannekote Thippaiah, MD, et al.
Published: (2021-05-01) -
Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism
by: Sumit Kumar Chakrabarti, et al.
Published: (2013-01-01) -
Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial
by: Jocelyn Fotso Soh, et al.
Published: (2022-09-01) -
Primary Hyperparathyroidism: lessons from two cases
by: Giuseppe Turiano, et al.
Published: (2019-04-01) -
A rare cause of hypercalcemia presenting with high parathormone levels: Familial hypocalciuric hypercalcemia
by: Okan Bakiner, et al.
Published: (2013-08-01)